1-6 of 6
Hai T. Tran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C18: Epithelial and mesenchymal phenotypic characterization and mutation detection in circulating tumor cells isolated from peripheral blood of non-small cell lung cancer patients with ApoStream® technology

Priya Balasubramanian, Vishal Gupta, David Hasegawa, Carmen Y. Lam, Ran An, Swetha Pratyusha Gunturu, Hai T. Tran, John V. Heymach, Darren W. Davis
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C18.
https://doi.org/10.1158/1535-7163.TARG-15-C18
Published: 01 December 2015
View article titled, Abstract C18: Epithelial and mesenchymal phenotypic characterization and mutation detection in circulating tumor cells isolated from peripheral blood of non-small cell lung cancer patients with ApoStream® technology
Journal Articles

Abstract C16: The use of an antibody independent method, ApoStream™, to isolate circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients and identification of EGFR mutations

Hai T. Tran, Tsao S. Anne, Katherine Richardson, Ben Legendre, Asifa Haider, Darren Davis, John Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C16.
https://doi.org/10.1158/1535-7163.TARG-15-C16
Published: 01 December 2015
View article titled, Abstract C16: The use of an antibody independent method, ApoStream™, to isolate circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients and identification of EGFR mutations
Journal Articles

Abstract C29: Characterization and identification of specific EGFR mutations in circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients using an antibody independent method, ApoStream™: An update report.

Hai T. Tran, Vladislava Melnikova, Anne S. Tsao, Frank V. Fossella, Faye M. Johnson, Vali Papadimitrakoupoulou, Katherine Richardson, Marcia E. Lewis, Ben Legendre, Kenna L. Anderes, Darren W. Davis, John V. Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C29.
https://doi.org/10.1158/1535-7163.TARG-13-C29
Published: 01 November 2013
View article titled, Abstract C29: Characterization and identification of specific EGFR mutations in circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients using an antibody independent method, ApoStream™: An update report.
Journal Articles

Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer

Lauren Averett Byers, F. Christopher Holsinger, Merrill S. Kies, William N. William, Adel K. El-Naggar, J. Jack Lee, Jianhua Hu, Adriana Lopez, Hai T. Tran, Shaoyu Yan, Zhiqiang Du, K. Kian Ang, Bonnie S. Glisson, Maria Gabriela Raso, Ignacio I. Wistuba, Jeffrey N. Myers, Waun-Ki Hong, Vali Papadimitrakopoulou, Scott M. Lippman, John V. Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1755–1763.
https://doi.org/10.1158/1535-7163.MCT-09-1047
Published: 09 June 2010
View article titled, Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
Open the PDF for Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer in another window
Journal Articles

Abstract A11: Lower baseline levels of plasma hepatocyte growth factor, IL‐6, and IL‐8 are correlated with greater tumor shrinkage in renal cell carcinoma patients treated with pazopanib

John V. Heymach, Hai T. Tran, Herbert A. Fritsche, Terrie G. Gornet, Yuan Liu, Dilip Rajagopalan, Anne‐Marie Martin, Katherine L. Baker, Louise Downie, Thomas E. Hutson, Robert A. Figlin, VEG102616 Team, Rafael G. Amado, Lini N. Pandite
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A11.
https://doi.org/10.1158/1535-7163.TARG-09-A11
Published: 10 December 2009
View article titled, Abstract A11: Lower baseline levels of plasma hepatocyte growth factor, IL‐6, and IL‐8 are correlated with greater tumor shrinkage in renal cell carcinoma patients treated with pazopanib
Journal Articles

Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells

Ralph G. Zinner, Brittany L. Barrett, Elmira Popova, Paul Damien, Andrei Y. Volgin, Juri G. Gelovani, Reuben Lotan, Hai T. Tran, Claudio Pisano, Gordon B. Mills, Li Mao, Waun K. Hong, Scott M. Lippman, John H. Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (3): 521–532.
https://doi.org/10.1158/1535-7163.MCT-08-0937
Published: 13 March 2009
View article titled, Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells
Open the PDF for Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells in another window
Includes: Supplementary data